Charity to double its annual spend to support new diagnostics, drugs, devices and digital solutions
The medical research charity LifeArc has committed to spending up to £1.3 billion by 2030 to tackle health challenges.
The funding, which was unveiled in the charity’s new strategy on 17 November, will support new diagnostics, drugs, devices and digital solutions to “transform” the way diseases such as motor neurone disease are prevented, identified and treated.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.